Which Tmax to be consider in case of b.i.d. dosing? [NCA / SHAM]

posted by Helmut Homepage – Vienna, Austria, 2016-04-13 13:49  – Posting: # 16199
Views: 3,279

Hi Maulik,

» » Why did you decide to take 12h interval, not 13h and 11h?
» Reply: The dosage regimen for Immediate release formulation is twice daily thats why second dosing done at 12.0 hours interval.

That’s not a justification!

» » » As Reference product is to be given two times a day at 12.00 hours interval …

BID does not necessarily mean τ 12 h. What does the label/SmPC of the IR product state? For a lot of “uncomplicated drugs” BID may as well allow for a “convenient” dose regimen (e.g., 7 a.m. and 10 p.m. = τ 15/9 h). For some drugs (antibiotics, anticonvulsants, …) a strictly equal dosing regimen is mandatory. Yet others (diurnal variation in PK) may mandate a fixed dose regimen with unequal intervals in order to minimize fluctuations. Hence, BE-proff’s question makes sense indeed.

Essentially it boils down to the target you had in mind developing the MR formulation. I would explore all PK-metrics in both intervals (pAUC0–τ, Cmax,0–τ, tmax,0–τ and pAUCτ–t, Cmax,τ–t, tmax,τ–t) as well as the global ones (AUC0–t, Cmax, tmax).

Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
20,135 posts in 4,245 threads, 1,385 registered users;
online 12 (1 registered, 11 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 05:14 CET

In the beginner’s mind there are many possibilities.
In the expert’s mind there are few.    Shunryu Suzuki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz